H.C. Wainwright Reiterates Buy Rating on Soleno Therapeutics Inc. (SLNO)

December 2, 2024 6:43 AM EST Send to a Friend
H.C. Wainwright analyst Raghuram Selvaraju reiterated a Buy rating and $70.00 price target on Soleno Therapeutics Inc. (NASDAQ: SLNO).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login